ArticleOncotarget2016

Chk1 inhibition significantly potentiates activity of nucleoside analogs in TP53-mutated B-lymphoid cells.

Jana Zemanova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.